Article
Dextranomer/hyaluronic acid has the potential to lower the cost and also the morbidity of repeated voiding cystourethrograms in children.
Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
Vaginal prolapse repair and sling surgery significantly reduce UUI
Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025
FDA grants marketing authorization to at-home diagnostic test for STIs
Expert discusses unique mechanism of action of UTI treatment gepotidacin